EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2025
CVR: 32770487
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262. The solvency ratio was 55%. The company had 18 employees in the financial year.
- Gross Profit
- DKK -9,158,236
- Profit/Loss
- DKK -21,948,253
- Equity
- DKK 23,950,262
- Total Assets
- DKK 43,556,541
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -9.2M | -21.9M | 24M | 18 |
| 2024 | - | -24M | -19.8M | 32.8M | 17 |
| 2023 | - | -38.9M | -55.6M | 41.9M | 26 |
| 2022 | - | -57.9M | -79.1M | 68.5M | 27 |
| 2021 | - | -7.8M | -27.2M | 97.3M | 21 |
Official annual report
How creditworthy is EXPRES2ION BIOTECHNOLOGIES ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2024. Gross profit came to DKK -24,035,211, and the net result was DKK -19,830,535.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.